Office of the Director, National Institutes of Health; Notice of Meeting, 5091 [2010-1897]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 20 / Monday, February 1, 2010 / Notices
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Agenda items for this meeting are subject
to change as priorities dictate.
Dated: January 25, 2010.
Carolyn M. Clancy,
Director.
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: January 25, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–1901 Filed 1–29–10; 8:45 am]
BILLING CODE 4160–90–M
[FR Doc. 2010–1897 Filed 1–29–10; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–M
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
5091
nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Agenda items for this meeting are subject
to change as priorities dictate.
Dated: January 25, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010–1896 Filed 1–29–10; 8:45 am]
BILLING CODE 4160–90–M
Office of the Director, National
Institutes of Health; Notice of Meeting
jlentini on DSKJ8SOYB1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Office
of AIDS Research Advisory Council.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Office of AIDS
Research Advisory Council.
Date: March 18, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: The theme of the meeting will be
‘‘HIV/AIDS and Aging.’’ The meeting will
address issues related to: increased rates of
new infections among older adults; impact of
long-term use of antiretroviral therapies in
HIV-infected individuals; and premature
aging in HIV-infected individuals. An update
also will be provided on the OARAC
Working Groups for HIV Treatment and
Prevention Guidelines.
Place: National Institutes of Health, 5635
Fishers Lane, Rockville, MD 20852.
Contact Person: Christina Brackna,
Coordinator, Program Planning and Analysis,
Office of Aids Research, Office of the
Director, NIH, 5635 Fishers Lane MSC 9310,
Suite 4000, Rockville, MD 20852, (301) 402–
8655, cm53v@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Centers home page: https://
www.oar.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
VerDate Nov<24>2008
18:35 Jan 29, 2010
Jkt 220001
Agency for Healthcare Research and
Quality
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10 (d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for the ARRA: Limited
Competition ‘‘NRSA CE Development
Award’’ (T32) applications are to be
reviewed and discussed at this meeting.
These discussions are likely to reveal
personal information concerning
individuals associated with the
applications. This information is
exempt from mandatory disclosure
under the above-cited statutes.
SEP Meeting on: ARRA: Limited
Competition ‘‘NRSA CE Development Award’’
(T32)
Date: March 3, 2010 (Open on March 3
from 1 p.m. to 1:15 p.m. and closed for the
remainder of the meeting).
Place: Hilton Rockville Executive Meeting
Center, 1750 Rockville Pike, Madison
Conference Room, Rockville, Maryland
20850.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meetings
In accordance with section 10(d) of
the Federal Advisory Committee Act as
amended (5 U.S.C., Appendix 2), the
Agency for Healthcare Research and
Quality (AHRQ) announces meetings of
scientific peer review groups. The
subcommittees listed below are part of
the Agency’s Health Services Research
Initial Review Group Committee.
The subcommittee meetings will be
closed to the public in accordance with
the Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications are to be reviewed and
discussed at these meetings. These
discussions are likely to involve
information concerning individuals
associated with the applications,
including assessments of their personal
qualifications to conduct their proposed
projects. This information is exempt
from mandatory disclosure under the
above-cited statutes.
1. Name of Subcommittee: Health Care
Technology and Decision Sciences.
Date: February 23–25, 2010 (Open from 8
a.m. to 8:15 a.m. on February 23 and closed
for remainder of the meeting).
Place: Marriott Bethesda North Hotel &
Conference Center, 5701 Marinelli Road,
Forest Glen Conference Room, Bethesda, MD
20852.
2. Name of Subcommittee: Health Systems
Research.
Date: February 24–25, 2010 (Open from 8
a.m. to 8:15 a.m. on February 24 and closed
for remainder of the meeting).
Place: Marriott Bethesda North &
Conference Center, 5701 Marinelli Road,
Linden Oak Conference Room, Bethesda, MD
20852.
3. Name of Subcommittee: Health Care
Quality and Effectiveness Research.
Date: March 3–4, 2010 (Open from 8:30
a.m. to 8:45 a.m. on March 3 and closed for
remainder of the meeting).
E:\FR\FM\01FEN1.SGM
01FEN1
]]>Agencies
[Federal Register Volume 75, Number 20 (Monday, February 1, 2010)]
[Notices]
[Page 5091]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-1897]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Office of AIDS Research Advisory Council.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Office of AIDS Research Advisory Council.
Date: March 18, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: The theme of the meeting will be ``HIV/AIDS and Aging.''
The meeting will address issues related to: increased rates of new
infections among older adults; impact of long-term use of
antiretroviral therapies in HIV-infected individuals; and premature
aging in HIV-infected individuals. An update also will be provided
on the OARAC Working Groups for HIV Treatment and Prevention
Guidelines.
Place: National Institutes of Health, 5635 Fishers Lane,
Rockville, MD 20852.
Contact Person: Christina Brackna, Coordinator, Program Planning
and Analysis, Office of Aids Research, Office of the Director, NIH,
5635 Fishers Lane MSC 9310, Suite 4000, Rockville, MD 20852, (301)
402-8655, cm53v@nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Centers home
page: https://www.oar.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: January 25, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-1897 Filed 1-29-10; 8:45 am]
BILLING CODE 4140-01-M
